These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2689396)

  • 21. High-dose cisplatin in patients with advanced malignancies.
    Blumenreich MS; Woodcock TM; Jones M; Richman SP; Gentile PS; Kubota TT; Allegra JC
    Cancer; 1985 Mar; 55(5):1118-22. PubMed ID: 4038468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix.
    de Wit R; van der Zee J; van der Burg ME; Kruit WH; Logmans A; van Rhoon GC; Verweij J
    Br J Cancer; 1999 Jul; 80(9):1387-91. PubMed ID: 10424740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous therapy with high-dose cisplatin and radiation for unresectable squamous cell cancer of the head and neck: a phase I-II study.
    Wheeler R; Salter M; Stephens S; Hardy I; Peters G; Urist M; Maddox W
    NCI Monogr; 1988; (6):339-41. PubMed ID: 3352778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study of cisplatin, hyperthermia, and lapatinib in patients with recurrent carcinoma of the uterine cervix in a previously irradiated area.
    van Meerten E; Franckena M; Wiemer E; van Doorn L; Kraan J; Westermann A; Sleijfer S
    Oncologist; 2015 Mar; 20(3):241-2. PubMed ID: 25660155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial results of phase I/II interstitial thermoradiotherapy for primary advanced and local recurrent tumors.
    Phromratanapongse P; Seegenschmiedt MH; Karlsson UL; Brady LW; Sauer R; Herbst M; Fietkau R
    Am J Clin Oncol; 1990 Jun; 13(3):259-68. PubMed ID: 2189290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.
    Masters GA; Haraf DJ; Hoffman PC; Drinkard LC; Krauss SA; Ferguson MK; Olak J; Samuels BL; Golomb HM; Vokes EE
    J Clin Oncol; 1998 Jun; 16(6):2157-63. PubMed ID: 9626216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
    Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
    J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
    Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
    Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperthermia and irradiation for locally recurrent previously irradiated breast cancer.
    Phromratanapongse P; Steeves RA; Severson SB; Paliwal BR
    Strahlenther Onkol; 1991 Feb; 167(2):93-7. PubMed ID: 2000551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial hyperthermia and iridium-192 treatment alone vs. interstitial iridium-192 treatment/hyperthermia and low dose cisplatinum infusion in the treatment of locally advanced head and neck malignancies.
    Schreiber DP; Overett TK
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):429-36. PubMed ID: 7673030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.
    Mornex F; Peignaux K; Germain T; Wautot V; Chouaki N; Bourayou N; Tourani JM
    Lung Cancer; 2013 Apr; 80(1):68-74. PubMed ID: 23332163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors.
    Choi KN; Rotman M; Aziz H; Sohn CK; Schulsinger A; Torres C; Har-El G; Chandra P; Bradley T; Rosenthal CJ
    Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):823-9. PubMed ID: 9369129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.
    Robins HI; Katschinski DM; Longo W; Grosen E; Wilding G; Gillis W; Kraemer C; Tiggelaar CL; Rushing D; Stewart JA; Spriggs D; Love R; Arzoomanian RZ; Feierabend C; Alberti D; Morgan K; Simon K; d'Oleire F
    Cancer Chemother Pharmacol; 1999; 43(5):409-14. PubMed ID: 10100597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parameters predictive for complications of treatment with combined hyperthermia and radiation therapy.
    Kapp DS; Cox RS; Fessenden P; Meyer JL; Prionas SD; Lee ER; Bagshaw MA
    Int J Radiat Oncol Biol Phys; 1992; 22(5):999-1008. PubMed ID: 1555992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC).
    van Harskamp G; Boven E; Vermorken JB; van Deutekom H; Stam J; Njo KH; Karim AB; Tierie AH; Golding RP; Pinedo HM
    Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1735-8. PubMed ID: 2822636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility study on daily administration of cis-diamminedichloroplatinum(II) in combination with radiotherapy.
    Keizer HJ; Karim AB; Njo KH; Tierie AH; Snow GB; Vermorken JB; Pinedo HM
    Radiother Oncol; 1984 Jan; 1(3):227-34. PubMed ID: 6542243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001).
    Prawira A; Brana-Garcia I; Spreafico A; Hope A; Waldron J; Razak AR; Chen EX; Jang R; O'Sullivan B; Giuliani M; Bayley A; Cho J; Wang L; Perez-Ordonez B; Weinreb I; Siu LL; Hansen AR
    Invest New Drugs; 2016 Oct; 34(5):575-83. PubMed ID: 27289242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.